Cellular and Molecular Mechanisms of FUS-related ALS/FTD
FUS相关ALS/FTD的细胞和分子机制
基本信息
- 批准号:10582582
- 负责人:
- 金额:$ 38.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:ALS patientsAmyotrophic Lateral SclerosisAnimal ModelAnimalsAwardAxonBehavioral AssayBiochemicalBiogenesisBiological AssayBrainCAG repeatCell Culture TechniquesCell modelCell physiologyComplexCytoplasmCytoplasmic GranulesDefectDiseaseDrosophila genusEctopic ExpressionFrontotemporal DementiaFunctional disorderGenesGeneticGenetic ScreeningGenetic TranscriptionGoalsHomologous GeneHumanLightLinkLongevityLower OrganismMammalian CellMediatingMicroRNAsModelingMolecularMotor NeuronsMutateMutationMyotonic DystrophyNerve DegenerationNeurodegenerative DisordersNeuromuscular JunctionNeuronsNuclearPathogenesisPathogenicityPathologicPathologyPathway interactionsPatientsPhosphorylationPhysiologicalProteinsRNARNA InterferenceRNA SplicingRNA metabolismRNA-Binding Protein FUSRNA-Binding ProteinsSMN expressionSMN protein (spinal muscular atrophy)Small Nuclear RNASpinal Muscular AtrophyTherapeutic InterventionToxic effectTranslationsUbiquitinVertebratesWorkcellular pathologycofactordisease-causing mutationflyfrontotemporal degenerationfrontotemporal lobar dementia amyotrophic lateral sclerosisglycogen synthase kinase 3 betahuman diseasein vivoinduced pluripotent stem cellknock-downmolecular pathologymotor neuron degenerationmutantnovelpatient subsetsprotein TDP-43recruitstress granuletraffickingtranscriptometranscriptome sequencingtranscriptomics
项目摘要
ALS is a late-onset progressive neurodegenerative disease caused by degeneration of motor
neurons, and a disease hallmark is the accumulation of ubiquitin-positive aggregates in
neuronal cytoplasm. FUS was identified as genes mutated in both familial and sporadic forms of
ALS. In fact, a subset of patients with frontotemporal dementia (FTD) show FUS pathology.
FUS, similar to TDP-43, is an RNA binding protein implicated in multiple aspects of RNA
metabolism, including splicing, trafficking, and translation. The precise mechanisms of mutated
FUS in ALS pathogenesis are not known.
To understand the molecular mechanisms of FUS-mediated neurodegeneration, we developed
cellular (mammalian primary neuronal and patient-derived iPSC motor neuron) and Drosophila
models that recapitulate key features of human disease including cytoplasmic mislocalization,
neuromuscular junction defects, locomotor dysfunctions, reduced life span, perturbed stress
granule dynamics and toxicity. We discovered muscleblind and drosha as unexpected and novel
modifiers of mutant FUS toxicity. MBNL proteins, highly conserved from lower organisms to
vertebrates, have been implicated in many neurodegenerative disorders, such as myotonic
dystrophy and CAG repeat diseases. The long-term goal is to identify modifiers of FUS toxicity
and understand their molecular mechanisms using mammalian cell culture and Drosophila
models. The objective of our current application is to determine how muscleblind and drosha
modulate FUS-mediated toxicity in Drosophila and FUS iPSC motor neurons. We hypothesize
that muscleblind and drosha regulate RNA splicing, SG dynamics and miRNA biogenesis that is
perturbed by pathogenic mutations in FUS. We will examine the impact of muscleblind and
drosha on cellular and molecular pathologies in FUS-associated neurodegeneration. We expect
to dissect the molecular pathways that could be exploited for developing therapeutic
interventions for ALS/FTD patients.
ALS 是一种迟发性进行性神经退行性疾病,由运动神经退行性疾病引起
神经元中泛素阳性聚集物的积累是一种疾病的标志
神经元细胞质。 FUS 被确定为家族性和散发性形式的基因突变
肌萎缩侧索硬化症。事实上,一部分额颞叶痴呆 (FTD) 患者表现出 FUS 病理。
FUS 与 TDP-43 类似,是一种 RNA 结合蛋白,与 RNA 的多个方面有关
新陈代谢,包括剪接、运输和翻译。突变的精确机制
FUS 在 ALS 中的发病机制尚不清楚。
为了了解 FUS 介导的神经变性的分子机制,我们开发了
细胞(哺乳动物原代神经元和患者来源的 iPSC 运动神经元)和果蝇
概括人类疾病关键特征的模型,包括细胞质错误定位,
神经肌肉接头缺陷、运动功能障碍、寿命缩短、压力扰动
颗粒动力学和毒性。我们发现muscleblind 和drosha 是出乎意料且新颖的
突变体 FUS 毒性的修饰剂。 MBNL 蛋白,从低等生物到高度保守
脊椎动物,与许多神经退行性疾病有关,例如强直性肌强直
营养不良和 CAG 重复疾病。长期目标是确定 FUS 毒性的调节剂
并利用哺乳动物细胞培养和果蝇了解其分子机制
模型。我们当前应用程序的目标是确定muscleblind 和drosha 如何
调节果蝇和 FUS iPSC 运动神经元中 FUS 介导的毒性。我们假设
muscleblind 和 drosha 调节 RNA 剪接、SG 动力学和 miRNA 生物合成
受到 FUS 致病性突变的干扰。我们将研究肌盲的影响
drosha 对 FUS 相关神经变性的细胞和分子病理学进行了研究。我们期望
剖析可用于开发治疗药物的分子途径
针对 ALS/FTD 患者的干预措施。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity.
- DOI:10.1093/hmg/ddw232
- 发表时间:2016-09-15
- 期刊:
- 影响因子:3.5
- 作者:Crippa V;Cicardi ME;Ramesh N;Seguin SJ;Ganassi M;Bigi I;Diacci C;Zelotti E;Baratashvili M;Gregory JM;Dobson CM;Cereda C;Pandey UB;Poletti A;Carra S
- 通讯作者:Carra S
Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy.
- DOI:10.1016/j.neuron.2014.12.031
- 发表时间:2015-01-07
- 期刊:
- 影响因子:16.2
- 作者:Scaramuzzino, Chiara;Casci, Ian;Parodi, Sara;Lievens, Patricia M. J.;Polanco, Maria J.;Milioto, Carmelo;Chivet, Mathilde;Monaghan, John;Mishra, Ashutosh;Badders, Nisha;Aggarwal, Tanya;Grunseich, Christopher;Sambataro, Fabio;Basso, Manuela;Fackelmayer, Frank O.;Taylor, J. Paul;Pandey, Udai Bhan;Pennuto, Maria
- 通讯作者:Pennuto, Maria
Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.
- DOI:10.1007/s00401-015-1530-0
- 发表时间:2016-04
- 期刊:
- 影响因子:12.7
- 作者:Daigle JG;Krishnamurthy K;Ramesh N;Casci I;Monaghan J;McAvoy K;Godfrey EW;Daniel DC;Johnson EM;Monahan Z;Shewmaker F;Pasinelli P;Pandey UB
- 通讯作者:Pandey UB
Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo
- DOI:10.1016/j.stemcr.2019.01.015
- 发表时间:2019-03-05
- 期刊:
- 影响因子:5.9
- 作者:Reinhardt, Lydia;Kordes, Susanne;Sterneckert, Jared L.
- 通讯作者:Sterneckert, Jared L.
Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death.
- DOI:10.1016/j.neuron.2014.12.010
- 发表时间:2014-12-17
- 期刊:
- 影响因子:16.2
- 作者:Wen X;Tan W;Westergard T;Krishnamurthy K;Markandaiah SS;Shi Y;Lin S;Shneider NA;Monaghan J;Pandey UB;Pasinelli P;Ichida JK;Trotti D
- 通讯作者:Trotti D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Udai B Pandey其他文献
Udai B Pandey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Udai B Pandey', 18)}}的其他基金
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
- 批准号:
10753403 - 财政年份:2023
- 资助金额:
$ 38.83万 - 项目类别:
Targeting epigenetic modifiers of androgen receptor activity and toxicity in SBMA
SBMA 中雄激素受体活性和毒性的表观遗传修饰因子
- 批准号:
9754495 - 财政年份:2019
- 资助金额:
$ 38.83万 - 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
- 批准号:
9303039 - 财政年份:2017
- 资助金额:
$ 38.83万 - 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
- 批准号:
9230443 - 财政年份:2014
- 资助金额:
$ 38.83万 - 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
- 批准号:
9014564 - 财政年份:2014
- 资助金额:
$ 38.83万 - 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
- 批准号:
8811504 - 财政年份:2014
- 资助金额:
$ 38.83万 - 项目类别:
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
FUS相关ALS/FTD的细胞和分子机制
- 批准号:
10370356 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
FUS相关ALS/FTD的细胞和分子机制
- 批准号:
9901635 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
Cellular and Molecular Mechanisms of FUS-related ALS/FTD
FUS相关ALS/FTD的细胞和分子机制
- 批准号:
9763021 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis
FUS相关肌萎缩侧索硬化症的细胞和分子机制
- 批准号:
8529133 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
相似国自然基金
无义介导的mRNA降解途径参与家族性肌萎缩侧索硬化症神经元损伤的机制及干预研究
- 批准号:82371871
- 批准年份:2023
- 资助金额:45 万元
- 项目类别:面上项目
基于新型深度学习算法和多组学研究策略鉴定非编码区剪接突变在肌萎缩侧索硬化症中的分子机制
- 批准号:82371878
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
泛素样蛋白在肌萎缩侧索硬化症发病过程中的作用和机制研究
- 批准号:82230038
- 批准年份:2022
- 资助金额:261 万元
- 项目类别:重点项目
神经先天免疫系统调控肌萎缩侧索硬化症微卫星重复扩增相关二肽重复蛋白清除的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
PCDHA9基因突变介导的肌萎缩侧索硬化症分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Investigation of UBQLN2 in neuronal dysfunction and ALS-FTD
UBQLN2 在神经元功能障碍和 ALS-FTD 中的研究
- 批准号:
10638277 - 财政年份:2023
- 资助金额:
$ 38.83万 - 项目类别:
NUP50 as a modifier and risk factor for TDP-43 pathology in FTD/ALS
NUP50 作为 FTD/ALS 中 TDP-43 病理的修饰剂和危险因素
- 批准号:
10800366 - 财政年份:2023
- 资助金额:
$ 38.83万 - 项目类别:
T cell immunity in a rare juvenile form of motor neuron disease
一种罕见的青少年运动神经元疾病中的 T 细胞免疫
- 批准号:
10595316 - 财政年份:2023
- 资助金额:
$ 38.83万 - 项目类别:
Phenotyping Corticospinal Axon Degeneration in Preclinical ALS Models.
临床前 ALS 模型中皮质脊髓轴突变性的表型分析。
- 批准号:
10732637 - 财政年份:2023
- 资助金额:
$ 38.83万 - 项目类别: